IB-RA (Innobioscience LLC)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIB-RA (Innobioscience LLC)
Drug Alias NameIB-RA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-reactive protein inhibitorsProstaglandin E2 receptor agonistsInterleukin-2 receptor antagonists +[5] 
TargetsCyclooxygenase-2Nuclear factor NF-kappa-B complexInterleukin-2 receptor +[5] 
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInnobioscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnobioscience Llc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A